Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
38.04
-0.08 (-0.21%)
Aug 15, 2025, 10:30 AM - Market open

Apogee Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
124.19141.79118.32151.89
Short-Term Investments
381.23378.86277.14-
Cash & Short-Term Investments
505.42520.65395.46151.89
Cash Growth
-25.26%31.66%160.36%-
Other Receivables
-4.71.21-
Receivables
-4.71.21-
Prepaid Expenses
10.72.621.740.11
Other Current Assets
-1.74-0.06
Total Current Assets
516.12529.71398.41152.06
Property, Plant & Equipment
17.0213.322.59-
Long-Term Investments
115.77210.42--
Other Long-Term Assets
8.860.50.4-
Total Assets
657.77753.95401.4152.06
Accounts Payable
5.681.072.140.42
Accrued Expenses
21.8524.2617.319.56
Current Portion of Leases
4.033.231.1-
Total Current Liabilities
31.5528.5620.569.98
Long-Term Leases
6.828.60.93-
Total Liabilities
38.3737.1621.499.98
Common Stock
00-2.25
Additional Paid-In Capital
1,0461,022503.35-
Retained Earnings
-427.35-305.92-123.77-39.79
Comprehensive Income & Other
0.690.920.332.14
Total Common Equity
619.4716.79379.91-35.39
Shareholders' Equity
619.4716.79379.91142.08
Total Liabilities & Equity
657.77753.95401.4152.06
Total Debt
10.8511.832.03-
Net Cash (Debt)
610.34719.24393.43151.89
Net Cash Growth
-22.30%82.82%159.02%-
Net Cash Per Share
10.4513.0315.7361.69
Filing Date Shares Outstanding
58.4258.0948.525
Total Common Shares Outstanding
58.4258.0648.525
Working Capital
484.57501.15377.85142.08
Book Value Per Share
10.6012.357.83-7.08
Tangible Book Value
619.4716.79379.91-35.39
Tangible Book Value Per Share
10.6012.357.83-7.08
Machinery
-1.29--
Leasehold Improvements
-0.86--
Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q